|
|
|
|
班級規模及環境--熱線:4008699035 手機:15921673576( 微信同號) |
|
每期人數限3到5人。 |
|
上課時間和地點 |
|
上課地點:【上海】:同濟大學(滬西)/新城金郡商務樓(11號線白銀路站) 【深圳分部】:電影大廈(地鐵一號線大劇院站)/深圳大學成教院 【北京分部】:北京中山學院/福鑫大樓 【南京分部】:金港大廈(和燕路) 【武漢分部】:佳源大廈(高新二路) 【成都分部】:領館區1號(中和大道) 【沈陽分部】:沈陽理工大學/六宅臻品 【鄭州分部】:鄭州大學/錦華大廈 【石家莊分部】:河北科技大學/瑞景大廈 【廣州分部】:廣糧大廈 【西安分部】:協同大廈
最近開課時間(周末班/連續班/晚班):2020年3月16日 |
|
實驗設備 |
|
☆資深工程師授課
☆注重質量
☆邊講邊練
☆合格學員免費推薦工作
★實驗設備請點擊這兒查看★ |
|
質量保障 |
|
1、培訓過程中,如有部分內容理解不透或消化不好,可免費在以后培訓班中重聽;
2、培訓結束后,授課老師留給學員聯系方式,保障培訓效果,免費提供課后技術支持。
3、培訓合格學員可享受免費推薦就業機會。 |
|
課程大綱 |
|
|
|
-
課程介紹:
Certified Clinical Research Coordinators (CCRCs) are expected to have general knowledge of:
????
? laboratory terminology, tests, and procedures
????
? basic math, including adding, subtracting, multiplying, dividing, and calculating percentages
????
As defined by the 2010 ACRP Job Analysis Survey, a Certified Clinical Research Coordinator (CCRC?) shall have proficiency in the following areas of clinical research:
-
課程大綱:
??????? I. Investigational Product Management
???????
?? Ensure adequacy of investigational product and other supplies at site
???????
? Ensure randomization and emergency codes of investigational product have been maintained
???????
? Ensure proper storage, dispensing, handling, and disposition of investigational product and other supplies
???????
? Reconcile investigational product and other supplies
???????
? Maintain accountability of investigational product
???????
? Prepare investigational product according to the protocol
???????
? Dispense investigational product according to the protocol
???????
? Retrieve investigational product and calculate subject compliance
???????
? Maintain randomization and emergency codes of investigational product dispensing
???????
? Prepare emergency use report
???????
Using knowledge of:
???????
? Investigational product (e.g., package insert, report of prior investigations, Investigator's Brochure)
???????
? Investigational product inventory
???????
? Investigational product accountability
???????
? Investigational product storage
???????
? Packaging and labeling
???????
? Supplemental/rescue/comparator product
???????
? Investigational product compliance (e.g., protocol, standard operating procedures, local governance)
???????
? Accountability records
????
II. Protocol
???????
? Evaluate protocol for feasibility
???????
? Evaluate congruence of data collection tools (e.g., case report form (CRF), electronic data capture (EDC) with the study protocol
???????
? Verify the eligibility of potential trial subjects
???????
? Contribute to protocol development
???????
? Coordinate protocol approval process
???????
? Review protocol for feasibility
???????
? Review protocol during Investigator’s meeting
???????
? Execute study per protocol
???????
? Recommend and Implement protocol amendments
???????
Using knowledge of:
???????
? Protocol development
???????
? Protocol submission and approval procedures
???????
? Clinical trial phase
???????
? Study design characteristics (e.g., double‐blind, crossover, randomized)
???????
? Study objective
???????
? Description of procedures
???????
? Amendment submission and approval procedures
???????
? Inclusion/exclusion criteria
???????
? Statistical plan
????
III. Safety
???????
? Assess safety during trial participation
???????
? Minimize potential risks to subject safety
???????
? Oversee safety risks (e.g., clinical holds, product recalls)
???????
? Report required adverse events to regulatory authorities and/or IRB/IEC
???????
? Ensure adverse events reporting is documented (e.g., serious, severe, moderate, mild, expected, unexpected)
???????
? Ensure reasons for subject discontinuation are documented (i.e., causes, contact efforts)
???????
? Handle medical monitor oversight
???????
? Conduct study‐related procedures and monitor the safety of the trial subjects and investigational staff
???????
? Manage and motivate the investigational staff and other disciplines involved, and take measures to minimize any potential risks
???????
? Inform the sponsor and IRB/IEC of any changes to the protocol or safety concerns and submit progress reports to the IRB/IEC per requirements
???????
? Review common laboratory values and alerts
???????
? Determine and document the causality of adverse events
???????
? Identify expected or unexpected results associated with investigational products
???????
? Implement Investigator’s plan of action for management of adverse event (e.g., stop investigational product; call, retest, treat subject)
???????
? Maintain follow‐up to determine resolution of adverse event
???????
? Report serious adverse event to Sponsor/CRO and IRB/IEC
???????
? Classify adverse events (i.e., serious, severe, moderate, mild, expected, unexpected)
???????
? Record adverse event and relevant information on source document
???????
? Document reasons for subject discontinuation (i.e., causes, contact efforts)
???????
? Document follow‐up medical care for study subjects, as applicable
???????
? Conduct safety monitoring/reporting activities
???????
? Initiate un‐blinding procedures
???????
Using knowledge of:
???????
? Investigator’s Brochure
???????
? Safety monitoring
???????
? Safety and clinical databases
???????
? Subject safety issues (e.g., toxicity, significant lab values)
???????
? Adverse events reporting
???????
? Serious adverse events reporting
???????
? Safety reporting requirements
????
IV. Trial Management
???????
? Verify investigator/site feasibility
???????
? Develop timelines for conducting and completing the clinical trial
???????
? Prepare and conduct initiation activities
???????
? Ensure appropriate training of the investigational staff
???????
? Develop a recruitment strategy and study management plan
???????
? Follow a recruitment strategy and study management plan
???????
? Schedule and coordinate pre‐study site visit
???????
? Identify minimum regulatory document requirements for site trial master file (e.g., country‐specific regulatory documents)
???????
? Ensure IRB/IEC review/approval of study and study documents
???????
? Facilitate site budget/contract approval process
???????
? Submit documents to regulatory authorities
???????
? Document and communicate site visit findings
???????
? Ensure clinical trial registry requirements are met
???????
? Ensure timely review of study data (e.g., laboratory results, x‐rays)
???????
? Maintain current vendor credentials (e.g., lab certification/licensure and normal ranges)
???????
? Prepare and conduct close‐out monitoring visit(s)
???????
? Prepare study summary and/or close‐out letter for IRB/IEC
???????
? Document protocol deviations/violations
???????
? Evaluate study for feasibility
???????
? Schedule subjects
???????
? Obtain informed consent and screen trial subjects
???????
? Prepare study documents for IRB/IEC and/or sponsor review/approval
???????
? Prepare study documentation (e.g., schedule of events, description of procedures)
???????
? Train site personnel on Sponsor/CRO and regulatory requirements for study conduct (e.g., protocol procedures, EDC)
???????
? Select the investigational staff and assign roles and responsibilities
???????
? Develop a recruitment strategy and site study management plan
???????
? Transmit CRFs to Data Management
???????
? Review CRF queries from Data Management
???????
? Coordinate study monitoring visits
???????
? Select and manage local vendors (e.g., laboratory, x‐ray, MRI)
???????
? Draft study specific tools (e.g., source document, tracking tools)
???????
? Obtain, negotiate, and seek approval of study budgets and clinical trial agreement
???????
? Conduct subject visits according to requirements
???????
? Implement corrective actions plans
???????
? Maintain trial master file (e.g., regulatory binder)
???????
? Communicate laboratory/diagnostic results with Principal Investigator and Sponsor/CRO
???????
? Maintain standards for handling hazardous goods (e.g., IATA)
???????
? Manage study supplies (e.g., lab kits, case report forms)
???????
? Maintain equipment (e.g., calibration and preventive maintenance)
???????
? Manage study record retention and availability
???????
? Manage financial agreements
???????
? Comply with subject privacy regulations
???????
? Prescreen telephone calls for eligibility requirements
???????
? Maintain subject screening/enrollment log
???????
? Collect, record, and report accurate and verifiable data
???????
? Manage study issues
???????
Using knowledge of:Site Activities
???????
? Contract budget negotiations and approval process
???????
? Monitoring guidelines/plan and tools
???????
? Disposition of unused study‐related materials (e.g., CRF at end of study, destruction of lab kits)
???????
? Equipment and supplies (e.g., x‐ray, computer, lab kits) and storage
???????
? Pre‐study site visit
???????
? Investigator's meeting
???????
? Site initiation
???????
? Monitoring visit
???????
? Close‐out visit
???????
? Site monitoring visit log
???????
? Site signature log
???????
? Delegation listing
???????
? Trial master file (e.g., site, sponsor)
???????
? Regulatory documents
???????
? Record retention
???????
? Visit reports (e.g., initiation, close‐out)
???????
? Final report
???????
? Progress reports
???????
Protocol Compliance
???????
? Project feasibility
???????
? Study project tools
???????
? Sample collection, shipment, and storage
???????
? Study management plan (e.g., timelines, data management)
???????
? Good Clinical Practice
???????
? Procedure manuals
???????
? Protocol deviations
???????
Subject Scheduling, Screening, Recruitment, and Retention
???????
? Project timelines
???????
? Recruitment plan/strategies
???????
? Subject compliance
???????
? Subject visit logistics
???????
? Subject selection, screening, and recruitment
???????
? Subject retention
???????
? Subject discontinuation
???????
? Clinical trial registry
???????
PI Oversight/Qualifications
???????
? Staff qualifications
???????
? Staff roles and responsibilities
???????
? Plan for staff oversight
???????
? Investigator qualifications/site selection (e.g., therapeutic area, education, experience)
???????
? Plan for ancillary staff education
???????
CRF/Source Documents
???????
? Data management activities
???????
? Communication documentation (e.g., telephone, email)
???????
? Data management plan
???????
? Data query resolution
???????
? Electronic data (e.g., electronic health records, electronic case report forms)
???????
? Case Report Form
???????
? Essential documentation, subject related and non‐subject related (e.g., past medical records, lab reports, protocol, IRB approvals)
???????
? Source documentation
???????
Consent/Assent
???????
? Vulnerable subject populations
???????
? Communication with subjects
???????
? Protection of human subjects
???????
? Subject reimbursement
???????
? Subject privacy regulations
???????
? Informed consent
???????
? Indemnification/insurance
????
V. Trial Oversight
???????
? Ensure consistency between the sites’ standard operation procedures (SOPs) and the study requirements
???????
? Ensure investigator/site protocol compliance
???????
? Facilitate investigator/site corrective actions
???????
? Ensure compliance with electronic data requirements (e.g., electronic health records, eCRF)
???????
? Ensure adequate site management
???????
? Prepare the study site for audits and inspections
???????
? Respond to or facilitate response to audit/inspection findings
???????
? Ensure proper collection, processing, and shipment of specimens (e.g., centrifuge, preparation of slides, freezing, refrigeration)
???????
? Ensure proper adverse event reporting by the investigator
???????
? Escalate problems to appropriate in‐house management
???????
? Investigate potential fraud and misconduct
???????
? Report potential fraud and misconduct
???????
? Ensure follow‐up medical care for study subjects is documented, as applicable
???????
? Ensure adequate consent and documentation
???????
? Ensure staff, facility, and equipment availability throughout the study
???????
? Ensure compliance with study requirements and regulations
???????
? Prepare for audits, inspections, and follow up
???????
? Ensure access to source data by authorized parties, in accordance with ICH‐GCP, and protect confidentiality by limiting unauthorized access
???????
? Ensure that IRB/IEC documentation is adequate and that details of the IRB/IEC composition are on file
???????
Using knowledge of:
???????
? Issues management (e.g., escalation)
???????
? Audit preparation
???????
? Regulatory standards
???????
? Audit documents
???????
? Project monitoring guidelines
???????
? Project investigator supervision requirements
|
|
|
|
|
|
???????
Troubleshooting Java Applications
? ? ? ? ? ? ? ?
Classpath Errors
? ? ? ? ? ? ? ?
Class Loaders
? ? ? ? ? ? ? ?
Common Java Errors
???????
Troubleshooting Servers
? ? ? ? ? ? ? ?
Native Libraries
? ? ? ? ? ? ? ?
Threading Architecture
? ? ? ? ? ? ? ?
Work Managers
? ? ? ? ? ? ? ?
Deadlocks
? ? ? ? ? ? ? ?
Overload Protection
? ? ? ? ? ? ? ?
Deployment Problems
???????
Troubleshooting JDBC
? ? ? ? ? ? ? ?
Data Source Management
? ? ? ? ? ? ? ?
Diagnostics
? ? ? ? ? ? ? ?
Debug Flags
? ? ? ? ? ? ? ?
Connectivity Problems
? ? ? ? ? ? ? ?
Connection Leaks
? ? ? ? ? ? ? ?
Database Availability
???????
Troubleshooting JMS
? ? ? ? ? ? ? ?
Management
? ? ? ? ? ? ? ?
MBean Hierarchy
? ? ? ? ? ? ? ?
Message Logging
? ? ? ? ? ? ? ?
Diagnostics
? ? ? ? ? ? ? ?
Debug Flags
? ? ? ? ? ? ? ?
Overload Protection
? ? ? ? ? ? ? ?
Lost Messages
? ? ? ? ? ? ? ?
Duplicate Messages
???????
Troubleshooting Security
? ? ? ? ? ? ? ?
SSL Internals
? ? ? ? ? ? ? ?
Keystore Management
? ? ? ? ? ? ? ?
Debug Flags
? ? ? ? ? ? ? ?
Common SSL Problems
? ? ? ? ? ? ? ?
Certificate Validation
? ? ? ? ? ? ? ?
Embedded LDAP
? ? ? ? ? ? ? ?
Security Audit
? ? ? ? ? ? ? ?
Common LDAP Problems
???????
Troubleshooting Node Manager
? ? ? ? ? ? ? ?
Internals
? ? ? ? ? ? ? ?
Security
? ? ? ? ? ? ? ?
Common Issues
???????
Troubleshooting Clusters
? ? ? ? ? ? ? ?
Plug-in Configuration
? ? ? ? ? ? ? ?
OHS Overview
? ? ? ? ? ? ? ?
Plug-in Connectivity
? ? ? ? ? ? ? ?
Plug-in Diagnostics
? ? ? ? ? ? ? ?
Unicast Communication
? ? ? ? ? ? ? ?
Replication Debug Flags
? ? ? ? ? ? ? ?
Typical Replication Issues
|